Alendronic acid/colecalciferol

In today's world, Alendronic acid/colecalciferol has become a topic of interest to a wide spectrum of society. The relevance of Alendronic acid/colecalciferol transcends borders and contexts, significantly impacting the way we live and relate. From its influence on politics, the economy, culture and technology, to its impact on people's daily lives, Alendronic acid/colecalciferol occupies a prominent place on the public agenda. In this article, we will explore the various dimensions of Alendronic acid/colecalciferol and its importance in the contemporary world, offering a comprehensive analysis that allows a deep understanding of its scope and relevance today.

Alendronic acid/colecalciferol
Combination of
Alendronic acidBisphosphonate
ColecalciferolVitamin
Clinical data
Trade namesFosamax Plus D, Fosavance, Adrovance, others
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: B3
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • CA: ℞-only
  • UK: POM (Prescription only)
  • US: ℞-only
  • EU: Rx-only
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
KEGG

Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women.

Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.

References

  1. ^ "Product monograph brand safety updates". Health Canada. 7 July 2016. Retrieved 3 April 2024.
  2. ^ a b "Fosavance Tablets - Summary of Product Characteristics (SmPC)". (emc). Retrieved 1 March 2020.
  3. ^ a b "Fosamax Plus D- alendronate sodium and cholecalciferol tablet". DailyMed. 16 August 2019. Retrieved 1 March 2020.
  4. ^ a b "Adrovance EPAR". European Medicines Agency (EMA). 26 February 2020. Retrieved 1 March 2020.
  5. ^ a b "Fosavance EPAR". European Medicines Agency (EMA). 9 October 2019. Retrieved 1 March 2020.
  6. ^ Von Schacht E, Dambacher MA, Ringe JD, Dukas L (April 2012). "". MMW Fortschritte der Medizin (in German). 154 (Suppl 1): 10–21. PMID 23427364.
  7. ^ "Drug Approval Package: Fosamax Plus D (Alendronate Sodium) NDA #021762". U.S. Food and Drug Administration (FDA). 8 June 2006. Retrieved 1 March 2020.


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia